None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: ? Adults aged 19 years or older who voluntarily provide written informed consent to participate in the study. ? Patients diagnosed with persistent atrial fibrillation who are scheduled to undergo catheter ablation for atrial fibrillation.
Exclusion criteria
Exclusion criteria: ? Prior history of catheter ablation or MAZE surgery for atrial fibrillation. ? Left atrial (LA) diameter exceeding 60 mm. ? End-stage renal disease (ESRD). ? History of prior open-heart surgery. ? Pregnancy or women of childbearing potential. ? Heart failure patients categorized as New York Heart Association (NYHA) functional class IV. ? Acute coronary syndrome (ACS) within the previous 3 months. ? Terminal illness with a life expectancy of less than 1 year. ? Any other condition deemed inappropriate for study participation by the investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Any documented atrial tachyarrhythmias excluding the initial 3-month blanking period. Documented atrial tachyarrhythmias | — |
Secondary
| Measure | Time frame |
|---|---|
| Atrial fibrillation burden;Repeat ablation;Use of antiarrhythmic drug therapy;Atrial Fibrillation Effect on Quality-of-Life (AFEQT) score;Stroke;Cardiovascular hospitalization;Bleeding;All cause mortality;Procedure-related complication;Procedure time;Radiation time;Left atrial global strain | — |
Countries
Korea, Republic of
Contacts
Samsung Medical Center